Evidence map›Paper›PMID 33381108›Full record

ArticleFrontiers in immunology2020

Endothelial Barrier Integrity Is Disrupted

Vanessa Araujo Gomes Santaterra, Maiara Marx Luz Fiusa, Bidossessi Wilfried Hounkpe, Francine Chenou, Wouitchekpo Vincent Tonasse, Loredana Nilkenes Gomes da Costa, Diego Garcia-Weber, Igor de Farias Domingos, Franciele de Lima, Ivanio Teixeira Borba-Junior and 7 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 2 countries.

Vanessa Araujo Gomes SantaterraSchool of Medical Sciences, University of Campinas, Campinas, Brazil.
Maiara Marx Luz FiusaSchool of Medical Sciences, University of Campinas, Campinas, Brazil.
Bidossessi Wilfried HounkpeSchool of Medical Sciences, University of Campinas, Campinas, Brazil.
Francine ChenouSchool of Medical Sciences, University of Campinas, Campinas, Brazil.
Wouitchekpo Vincent TonasseSchool of Medical Sciences, University of Campinas, Campinas, Brazil.
Loredana Nilkenes Gomes da CostaSchool of Medical Sciences, University of Campinas, Campinas, Brazil.
Diego Garcia-WeberCentro de Biologia Molecular Severo Ochoa, Consejo Superior de Investigaciones Cientificas, Universidad Autonoma de Madrid, Madrid, Spain.
Igor de Farias DomingosGenetics Postgraduate Program, Federal University of Pernambuco, Recife, Brazil.
Franciele de LimaSchool of Medical Sciences, University of Campinas, Campinas, Brazil.
Ivanio Teixeira Borba-JuniorSchool of Medical Sciences, University of Campinas, Campinas, Brazil.
Aderson da Silva AraújoDepartment of Internal Medicine, Hematology and Hemotherapy Foundation of Pernambuco (HEMOPE), Recife, Brazil.
Antonio Roberto Lucena-AraújoGenetics Postgraduate Program, Federal University of Pernambuco, Recife, Brazil.
Marcos André Cavalcante BezerraGenetics Postgraduate Program, Federal University of Pernambuco, Recife, Brazil.
Magnun Nueldo Nunes Dos SantosSchool of Medical Sciences, University of Campinas, Campinas, Brazil.
Fernando Ferreira CostaSchool of Medical Sciences, University of Campinas, Campinas, Brazil.
Jaime MillánCentro de Biologia Molecular Severo Ochoa, Consejo Superior de Investigaciones Cientificas, Universidad Autonoma de Madrid, Madrid, Spain.
Erich Vinicius De PaulaSchool of Medical Sciences, University of Campinas, Campinas, Brazil.
Universidade Estadual de Campinas (UNICAMP) · BRUniversidade Federal de Pernambuco · BRConsejo Superior de Investigaciones Científicas · ESFundação Hemopa · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Free extracellular heme has been shown to activate several compartments of innate immunity, acting as a danger-associated molecular pattern (DAMP) in hemolytic diseases. Although localized endothelial barrier (EB) disruption is an important part of inflammation that allows circulating leukocytes to reach inflamed tissues, non-localized/deregulated disruption of the EB can lead to widespread microvascular hyperpermeability and secondary tissue damage. In mouse models of sickle cell disease (SCD), EB disruption has been associated with the development of a form of acute lung injury that closely resembles acute chest syndrome (ACS), and that can be elicited by acute heme infusion. Here we explored the effect of heme on EB integrity using human endothelial cell monolayers, in experimental conditions that include elements that more closely resemble

Indexed as

Anemia, Sickle CellAntigens, CDCadherin 5CadherinsHemeHemopexinHumansHuman Umbilical Vein Endothelial CellsAntigens, CDCadherin 5CadherinsHemeHemopexindanger-associated molecular patternelectric cell-substrate impedance sensingendothelial barrierhemehemopexinsickle cell disease

Identifiers

PMID33381108
PMCPMC7767881
OpenAlexW3112874762

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.